As a wave of patent expirations encroaches upon many of the world’s top drugmakers, companies will need to be diligent in ...

Recent health news highlights include Amgen addressing bone density concerns, AstraZeneca revising its financial outlook ...

This article summarizes key developments in the health sector including a lawsuit blocking UnitedHealth's purchase of ...

View the full release here: "We are honored to be recognized with the Prix Galien Award for Best Digital Health Solution," ...

Neurogene shares tumbled 35% last night after it disclosed that a pediatric patient with Rett syndrome experienced a severe ...

As the company restructures, it will pivot to selling genetic tests to consumers and using that data for research. Also: medicinal and tech advancements in cancer care; research monkeys roundup.

Stacker consulted research from Yale Medical School and the World Health Organization to find how SARS-CoV-2 has evolved ...

Dr. Mackay is a highly accomplished R&D executive with more than 30 years of pharmaceutical and biotech R&D experience, including leadership roles at Pfizer, AstraZeneca and Alexion. SpringWorks uses ...

GSK’s departure comes as the industry anticipates the incoming Trump administration and as it continues to grapple with the threat of the BIOSECURE Act and losses of legal challenges to the IRA’s drug ...

Ruane specifically targeted individuals, such as Sir Chris, and the chief executive officer of Covid vaccine developer Pfizer in a series of posts ... In response to the creator of the AstraZeneca ...

The Galien Foundation was established to foster and reward outstanding achievements in improving the global human condition ...